Basel scores tenth place in quality of living ranking
Basel among the ten cities with the highest quality of living in the world, according to a survey from the consultancy group Mercer. The city ranking can help companies decide where to open a new office.
Expats have given Basel some of the highest possible scores, with the city coming in tenth place in Mercer’s global quality of living ranking. Vienna came in first place, followed by Zurich. Third place was shared among Auckland, Munich and Vancouver.
Two other Swiss cities made it into the top 15, with Geneva in 8th and Bern in 14th.
The lowest ranked cities were Yemen’s capital Sanaa (229), the capital of the Central African Republic, Bangui (230) and Iraq’s capital Baghdad (231) at the bottom of the list.
Mercer conducts a survey each year with expatriates on how they evaluate quality of living in 450 cities throughout the world, 231 of which are included in the ranking. The living conditions are analyzed according to 39 categories, including health services, education and transportation, as well as other public services.
The annual city ranking also helps multinational companies compare different locations, which can be useful when considering where to open a new office, writes Mercer in a statement.
Basel was included in the Mercer city ranking for the first time in 2017, when it also made it into the prestigious top ten.
Share this article
You might also be interested in
The Basel-based biotechnology firm VectivBio has received a capital injection of 110 million US dollars from both new and existing...Read More
The Allschwil-based company Polyphor has received a second funding award from the global consortium CARB-X to combat antimicrobial resistance. Polyphor...Read More
The COVID-19 pandemic has hit economies worldwide – and we have not yet overcome it. However, Switzerland is among the...Read More
The Basel-based biotechnology firm Monte Rosa Therapeutics has raised a total of 96 million US dollars after closing a successful...Read More
The Basel-based pharmaceutical supplier Lonza is supporting the US firm Humanigen in the development of a potential coronavirus therapeutic. Lonza...Read More